Open Access · Peer Reviewed

Drug Safety Reports (DSR)

DSR publishes rapid, rigorously reviewed drug safety case reports, pharmacovigilance analyses, and risk communication. We welcome reports on small molecules, biologics, vaccines, and advanced therapies.

Aims & Scope

DSR focuses on adverse event case reports, post-marketing safety observations, safety signal detection, medication error reports, risk minimization strategies, and benefit–risk evaluations.

  • Case reports & case series of suspected adverse reactions
  • Disproportionality and signal detection studies
  • Real-world evidence and registry analyses
  • Methodology and reporting standards in pharmacovigilance

Why Open Access?

Safety information should be globally accessible to clinicians, regulators, and patients. All articles are free to read and reuse with attribution.

LicenseCC BY 4.0
PreprintsEncouraged; cite DOI/version
DataShare anonymized data when possible
CodeProvide repositories or appendices

Article Types

  • Drug Safety Case Report
  • Brief Report / Rapid Communication
  • Method / Resource
  • Review / Perspective

Author Guidelines

  1. Prepare your manuscript (IMRaD structure where applicable). Use structured abstracts for case reports: Background, Case, Assessment, Outcome.
  2. Ethics: De-identify patient data; obtain consent where required. Follow CARE and CONSORT-A guidelines where relevant.
  3. Formatting: Upload as PDF/Word; figures as PNG/SVG; include a completed reporting checklist.
  4. Availability: Data and code availability statements are mandatory.

Processing Charge (APC): TBD (waivers available for low- and middle-income countries).

Peer Review Policy

Single-anonymous by default with optional open reviews. Editorial decisions are based on methodological soundness and clarity.

Indexing

Planned: DOAJ, Google Scholar, Crossref DOI registration. Early articles receive DOIs upon acceptance.

Journal Issues

Browse volumes and issues. Click an issue to view its table of contents.

Select an issue to see contents

The table of contents for the selected issue will appear here.

Latest Articles

Replace the placeholders below with real content or wire this section to your backend.

Editorial Board

  • Editor-in-Chief: To be announced
  • Associate Editors: Pharmacovigilance, Clinical Pharmacology, Biostatistics
  • Advisory Board: Regulatory science, Patient safety, Epidemiology

Contact

For inquiries and proposals: editor@openfreescience.com


We only send acceptance & new issue announcements.